UCB Acquisitions
UCB has acquired 8 companies and its latest acquisition was Zogenix, Inc. on Jan 2022
COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Zogenix, Inc.
Jan 2022
Source »$1.9B
Zogenix is a California-based biopharmaceutical company that develops and commercializes transformative therapies for the treatment of epilepsy and mitochondrial diseases.
Handl Therapeutics BV
Nov 2020
Source »undisclosed
Handl Therapeutics is a biotechnology company that develops and commercializes gene therapies for the treatment of neurodegenerative diseases.
Engage Therapeutics, Inc.
Jun 2020
Source »$125M
Engage Therapeutics is a biopharmaceutical company that develops a hand-held inhaler for the treatment of patients with epileptic seizures.
Frequently Asked Questions about UCB
What companies did UCB acquire?
Companies acquired by UCB include Zogenix, Handl Therapeutics and Engage TherapeuticsHow many acquisitions does UCB have?
UCB has acquired 8 companies including Zogenix, Handl Therapeutics and Engage Therapeutics.
How many acquisitions did UCB make in 2022?
In 2022 UCB acquired 1 companies including Zogenix.